Mark Bamforth - Profile and Investment Details

Investor Profile

Mark Bamforth is a Angel/Individual based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Avid Bioservices, Thymmune, CONTINUUS Pharmaceuticals, Celtic Renewables, Ampersand Capital Partners, CANbridge Pharma, PNEUMAGEN LIMITED, Inceptor Bio, Dxcover, PneumoWave, Kincell Bio, Talking Medicines, MassBio, Kinvard Bio, EnteroBiotix, . Over time, Mark Bamforth has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Mark Bamforth is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Databases, Wellness, Enterprise Software, Consumer Goods, Energy, Antibiotics, Engineering, Information Services, Golf Equipment, Tech, Biotechnology, Research, Consumer Software, Agriculture, Renewable Energy, Information Technology, B2B, Pharmaceuticals may find it worthwhile to explore potential connections with Mark Bamforth, as their portfolio suggests a familiarity and interest in this area.

Understanding Mark Bamforth’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.